EU Proposes Recall Of Clopidogrel Because Of GMP Failures At Indian Glochem
This article was originally published in PharmAsia News
Executive Summary
Swiss company Acino Pharma says it is unnecessary to recall its generic clopidogrel products from the EU market, even though its Indian API supplier, Glochem Industries, failed a good manufacturing practices inspection